|
ANP32A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.21869999994517E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.968100E-04 |
| Normal-vs-Stage2 |
1.284150E-03 |
| Normal-vs-Stage3 |
3.87980000016164E-07 |
| Normal-vs-Stage4 |
4.31320000000568E-05 |
| Stage1-vs-Stage2 |
3.181400E-01 |
| Stage1-vs-Stage3 |
1.332290E-02 |
| Stage1-vs-Stage4 |
1.059970E-01 |
| Stage2-vs-Stage3 |
4.491800E-01 |
| Stage2-vs-Stage4 |
7.567000E-01 |
| Stage3-vs-Stage4 |
6.243600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.75659999998879E-06 |
| Normal-vs-AfricanAmerican |
1.440670E-04 |
| Normal-vs-Asian |
7.265600E-02 |
| Caucasian-vs-AfricanAmerican |
1.632390E-01 |
| Caucasian-vs-Asian |
6.117600E-01 |
| AfricanAmerican-vs-Asian |
9.669000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.7155000000546E-06 |
| Normal-vs-Female |
2.401200E-04 |
| Male-vs-Female |
1.988240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.596070E-02 |
| Normal-vs-Age(41-60Yrs) |
1.64086999999702E-05 |
| Normal-vs-Age(61-80Yrs) |
7.91340000000362E-05 |
| Normal-vs-Age(81-100Yrs) |
7.031700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.719600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.853200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.407800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.810400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.538040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.056800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.983600E-01 |
| Normal-vs-Grade 2 |
4.229700E-04 |
| Normal-vs-Grade 3 |
1.28099999996412E-06 |
| Normal-vs-Grade 4 |
7.86200000000292E-05 |
| Grade 1-vs-Grade 2 |
1.997560E-02 |
| Grade 1-vs-Grade 3 |
1.003100E-03 |
| Grade 1-vs-Grade 4 |
1.759140E-03 |
| Grade 2-vs-Grade 3 |
4.193600E-02 |
| Grade 2-vs-Grade 4 |
9.137600E-02 |
| Grade 3-vs-Grade 4 |
8.404800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.306040E-02 |
| Normal-vs-ccB subtype |
1.86899999998769E-06 |
| ccA subtype-vs-ccB subtype |
3.389600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.68160000005402E-06 |
| Normal-vs-N1 |
2.767500E-02 |
| N0-vs-N1 |
8.713000E-01 |
|
|
